Diversified Healthcare Trust (NASDAQ: DHC) stock jumped 0.95% on Friday to $2.12 against a previous-day closing price of $2.10. With 1.21 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.4 million shares. During the session, the REIT – Healthcare Facilities company that operates in wider Real Estate sector, reached to the highest price of $2.1950 whereas the lowest price it dropped to was $2.1050. The 52-week range on DHC shows that it touched its highest point at $3.30 and its lowest point at $0.61 during that stretch. It currently has a 1-year price target of $4.50. With its current market cap of 509.75 million, DHC has annualized dividend of $0.04 while the current yield stands at 1.89%. Beta for the stock currently stands at 1.90.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of DHC was up-trending over the past week, with a rise of 2.42%, but this was up by 13.37% over a month. Three-month performance dropped to -26.39% while six-month performance rose 112.00%. The stock gained 98.13% in the past year, while it has gained 227.77% so far this year. A look at the trailing 12-month EPS for DHC yields -1.07 with Next year EPS estimates of -0.86. For the next quarter, that number is -0.24. This implies an EPS growth rate of 13.43% for this year and 17.31% for next year.
Float and Shares Shorts:
At present, 239.69 million DHC shares are outstanding with a float of 215.79 million shares on hand for trading. On Oct 30, 2023, short shares totaled 6.26 million, which was 2.60% higher than short shares on Sep 28, 2023. In addition to Mr. Adam David Portnoy as the firm’s Managing Chair of the Board, Ms. Jennifer F. Francis serves as its President, CEO & Managing Trustee.
Through their ownership of 86.68% of DHC’s outstanding shares, institutional investors have majority control over the company.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for DHC since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With DHC analysts setting a high price target of $4.50 and a low target of $4.50, the average target price over the next 12 months is $4.50. Based on these targets, DHC could surge 112.26% to reach the target high and rise by 112.26% to reach the target low. Reaching the average price target will result in a growth of 112.26% from current levels.
Summary of Insider Activity:
Insiders traded DHC stock several times over the past three months with 2 Buys and 2 Sells. In these transactions, 80,000 shares were bought while 22,925 shares were sold. The number of buy transactions has increased to 10 while that of sell transactions has risen to 3 over the past year. The total number of shares bought during that period was 240,000 while 42,925 shares were sold.